Zangani Investor Community
Week in Review: August 27 , 2010

Probiotics Offer Relief for Sick Children

Two recently published studies indicate the potential of probiotics to relieve colic in infants and diarrhea in children.

The first study, published in the journal Pediatrics, concluded that Lactobacillus reuteri (L. reuteri DSM 17 938) improved symptoms of infantile colic and was well tolerated and safe in early breastfed infants at a dose of 108 colony-forming units per day. Gut microbiota changes induced by the probiotic could be involved in the observed clinical improvement, researchers said.

This study randomly assigned 50 exclusively breastfed colicky infants, diagnosed according to modified Wessel's criteria, to receive either L reuteri DSM 17 938 or placebo daily for 21 days. Parental questionnaires monitored daily crying time and adverse effects. Stool samples were collected for microbiologic analysis...(READ MORE)


Follow ZANGANI on Twitter!


NEWS


BREAKING NEWS: FDA Confirms WPI Study Linking XMRV to Chronic Fatigue Syndrome

The FDA issued the following news release today:

Study: Presence of murine leukemia virus related gene sequences found in CFS patients

Researchers have found murine leukemia viruses (MLV) related gene sequences in blood samples collected from patients diagnosed with chronic fatigue syndrome (CFS) and some healthy blood donors, according to a study published online today by the scientific journal Proceedings of the National Academy of Sciences (PNAS)...(READ MORE)



BLOGS

Rodman & RenshawThe Chinese Pharmaceutical Industry: Fortnightly Update 8/23/2010

Renhuang Pharmaceuticals (AMEX: CBP, Not Rated) Received Patent for Package Design for Compound Honeysuckle Granules

QRxPharma (ASX: QRX, Note Rated) Received Frost & Sullivan Award for Innovative Pain Relief Product MoxDuo

Jiangbo Pharmaceuticals (NASDAQ: JGBO, Not Rated) Launched Felodipine Sustained Release Tablets

Simcere Pharmaceutical Group (NYSE: SCR, Not Rated) Received SFDA Approval for Palonosetron

NeoStem (AMEX: NBS, Not Rated) Collaborated with the Schepens Eye Research Institute to Study VSEL™ Technology

Sinobiopharma (OTC: SNBP, Not Rated) Signed Agreement to Co-Develop, Manufacture and Promote Eplerenone

Weikang Bio-Technology (OTC: WKBT, Not Rated) Announced Plans to Launch New Therapeutics in 4Q10(READ MORE)


VIDEOS

HIV Shoots Up

Strict laws on the criminalization of drug use and drug users are fueling the spread of HIV and other serious harms associated with the criminal market and should be reviewed, say experts in this series of articles, published to coincide with the 18th International AIDS Conference in Vienna, which runs from 18 to 23 July 2010. In this video accompanying the articles, epidemiologist Elizabeth Pisani and other leading commentators describe which countries are leading the way in tackling HIV infection among injecting drug users...(READ MORE)


INVITATION to Join Pharma Finance on GroupSite

Pharma Finance
The Zangani Investor Community proudly presents the official Pharma Finance group, our Conference community powered by GroupSite.com platform for groups.. This group has been made available for exchanging information between professionals creating a collaboration of opinions, ideas and advice with individuals interested in scientific and technological advancements for better living and an environmentally friendly surrounding.

Please click the link below so you may quickly and easily participate in Pharma Finance. Signup is simple and takes less than a minute.

Join Pharma Finance


INVITATION to Join Let's Combat Pain
Palliative Medicine
The Zangani Investor Community proudly presents the Let's Combat Pain group, powered by GroupSite.com. We would like to promote the bridging among individuals who have a common interest in the study and care of patients with chronic pain.

Please click the link below so you may quickly and easily participate in Let's Combat Pain. Signup is simple and takes less than a minute.

Join Let's Combat Pain


INVITATION to Join Medical Food
Palliative Medicine

Indications and benefits of medical food based therapy are still poorly known to health care professionals. We would like to create a professional network among interested parties, and invite everyone to share opinions, comments, expertise, and much more on medical food research and development. One of the network intents is to foster a national and international network of information among stakeholders, including biotech, angel investors, non-profit foundations, researchers, academicians, and help exchange experience, knowledge, investments in research to generate or rediscover medical food products with vital health benefits This site is a public meeting place that provides members of The Medical Food Group a discussion forum and a file storage. We encourage you to upload your photo, complete your profile, and participate.

Join Medical Food

© 2010 Zangani Investor Community,
"Investor Community" is a Registered Trademark of L.G. Zangani LLC